ARYA Sciences Acquisition IV Stock Price, News & Analysis
Company Description
ARYA Sciences Acquisition IV (NASDAQ: ARYD) is a publicly traded biological product (except diagnostic) manufacturing company in the Blank Checks sector. The company has a market capitalization of $50.0M, ranking #5,630 among all listed U.S. companies by market cap.
ARYD stock has declined 100.0% over the past year. Shares last traded at $11.54.
This page provides a comprehensive overview of ARYD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ARYA Sciences Acquisition IV (ARYD) stock last traded at $11.54. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $50.0M, ARYD is classified as a micro-cap stock with approximately 3.8M shares outstanding.
Latest News
ARYA Sciences Acquisition IV has 5 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, clinical trial, IPO, offering. View all ARYD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ARYD Company Profile & Sector Positioning
ARYA Sciences Acquisition IV (ARYD) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Blank Checks sector and is listed on the NASDAQ.